RLYB Rallybio Corporation
$15.93▼ -3.66%
Healthcare
Other
Volume 52.6K
Avg Volume (10D) 24.0K
Key Metrics & Fundamentals
Market Cap
$84.63M
P/E Ratio
3.5
Div Yield
0.00%
52W Range
3.67 - 17.57
% vs 50 MA
-5.19%
% vs 200 MA
24.65%
RSI-14
36.5
MACD Histogram
-0.0600
Beta (1Y vs SPY)
0.60
Free Cash Flow
$45.92M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$55.65M
COGS
–
Operating Exp
$5.65M
Operating Income
-$5.65M
EBIT
-$5.65M
Pretax Income
$44.99M
Net Income
$43.67M
EPS (Diluted)
7.53
Price & Volume History
Loading chart…
Recent News
No recent news found for RLYB.
Financial Overview - Income Statement
Quarterly
Mar 2026
See RLYB's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.